From: Timed up and go test predicts mortality in older adults in Peru: a population-based cohort study
Characteristic | Survived N = 346 | Dead (all-cause) N = 81 | p-value | Dead by Infections or Accidents N = 43 | Dead by NCD N = 38 | p-value |
---|---|---|---|---|---|---|
Gender | ||||||
Male | 117 (33.82%) | 42 (51.85%) | 0.003b | 22 (51.16%) | 20 (52.63%) | 0.895b |
Female | 229 (66.18%) | 39 (48.15%) | 21 (48.84%) | 18 (47.37%) | ||
Age (years); Median (IQR) | 67 (63–74) | 76 (68–83) | < 0.001e | 78 (69–83) | 75.5 (67–84) | 0.336e |
Civil Status | ||||||
Married or Cohabitation | 219 (63.29%) | 53 (65.43%) | 0.719b | 27 (62.79%) | 26 (68.42%) | 0.595b |
Single, Divorced or Widower | 127 (36.71%) | 28 (34.57%) | 16 (37.21%) | 12 (31.58%) | ||
Education | ||||||
Higher | 68 (19.65%) | 14 (17.28%) | 0.200b | 6 (13.95%) | 8 (21.05%) | 0.235c |
Secondary | 130 (37.57%) | 23 (28.40%) | 9 (20.93%) | 14 (36.84%) | ||
Primary | 132 (38.15%) | 37 (45.68%) | 23 (53.49%) | 14 (36.84%) | ||
No Education | 16 (4.62%) | 7 (8.64%) | 5 (11.63%) | 2 (5.26%) | ||
Functional Parameters | ||||||
Gait Speed (m/s); Mean ± SD | 1.03 ± 0.25 | 0.87 ± 0.34 | < 0.001d | 0.81 ± 0.32 | 0.94 ± 0.35 | 0.081d |
Timed Up and Go test (sec); Median (IQR) | 10 (9–12) | 12 (10–16) | < 0.001e | 13 (10–18) | 10.85 (9–15) | 0.037e |
Clinical Variables | ||||||
Abdominal perimeter (centimeters); Median (IQR) | 98.75 (91–105) | 100 (94–107) | 0.169e | 98 (91–106) | 101 (97–108) | 0.191e |
Weight (kilograms); Median (IQR) | 65 (56–74) | 65 (55.5–73) | 0.741e | 62.5 (55–70) | 66.8 (57–75.5) | 0.168e |
Malnutrition | 94 (27.17%) | 18 (22.22%) | 0.362b | 10 (23.26%) | 8 (21.05%) | 0.812b |
Obesity | 245 (70.81%) | 56 (69.14%) | 0.766b | 25 (58.14%) | 31 (81.58%) | 0.023b |
Dyslipidemia | 214 (61.85%) | 46 (56.79%) | 0.401b | 24 (55.81%) | 22 (57.89%) | 0.850b |
Diabetes Mellitusa | 62 (17.92%) | 13 (16.05%) | 0.691b | 7 (16.28%) | 6 (15.79%) | 0.952b |
Arterial Hypertensiona | 169 (48.84%) | 51 (62.96%) | 0.022b | 25 (58.14%) | 26 (68.42%) | 0.339b |
Heart Diseasesa | 25 (7.23%) | 13 (16.05%) | 0.012b | 5 (11.63%) | 8 (21.05%) | 0.249b |
Strokea | 12 (3.47%) | 1 (1.23%) | 0.477c | 0 (0.00%) | 1 (2.63%) | 0.284c |
Rheumatological Diseasesa | 128 (36.99%) | 21 (25.93%) | 0.060b | 11 (25.58%) | 10 (26.32%) | 0.940b |
Respiratory Diseasesa | 18 (5.20%) | 8 (9.88%) | 0.123c | 5 (11.63%) | 3 (7.89%) | 0.574c |
Tuberculosisa | 5 (1.45%) | 3 (3.70%) | 0.179c | 2 (4.65%) | 1 (2.63%) | 1.000c |
Familial dysfunctiona | 74 (21.39%) | 21 (25.93%) | 0.377b | 16 (37.21%) | 5 (13.16%) | 0.014b |
Sociofamily impairment | 204 (58.96%) | 58 (71.60%) | 0.035b | 34 (79.07%) | 24 (63.16%) | 0.113b |
Cognitive impairment | 35 (10.12%) | 18 (22.22%) | 0.003b | 7 (16.28%) | 11 (28.95%) | 0.171b |
Insomniaa | 249 (71.97%) | 63 (77.78%) | 0.288b | 33 (76.74%) | 30 (78.95%) | 0.812b |
Depression | 66 (19.08%) | 15 (18.52%) | 0.908b | 9 (20.93%) | 6 (15.79%) | 0.552b |
Falls | 113 (32.66%) | 31 (38.27%) | 0.336b | 19 (44.19%) | 12 (31.58%) | 0.244b |
Edentulous | 294 (84.97%) | 76 (93.83%) | 0.035b | 41 (95.35%) | 35 (92.11%) | 0.661c |
Incontinencea | 80 (23.12%) | 19 (23.46%) | 0.949b | 11 (25.58%) | 8 (21.05%) | 0.631b |
Visual problem | 259 (74.86%) | 62 (76.54%) | 0.752b | 31 (72.09%) | 31 (81.58%) | 0.315b |
Hearing problem | 139 (40.17%) | 41 (50.62%) | 0.087b | 20 (46.51%) | 21 (55.26%) | 0.432b |
Polypharmacy | 135 (39.02%) | 39 (48.15%) | 0.132b | 24 (55.81%) | 15 (39.47%) | 0.142b |
Tobacco Consumption | 32 (9.25%) | 6 (7.41%) | 0.828b | 1 (2.33%) | 5 (13.16%) | 0.094c |